First Author
|
Title
|
Journal
|
Publication Date
|
PubMed link
|
Updated date
|
Lúcia M
|
Human CMV-specific T-cell responses in kidney transplantation; toward changing current risk- stratification paradigm.
|
Transpl Int
|
2014 Mar
|
Link
|
2014.4.30
|
Abate D
|
Comparison of cytomegalovirus (CMV) enzyme-linked immunosorbent spot and CMV immunosorbent spot and CMV quantiferon gamma interferon- releasing assays in assessing risk of CMV infection in kidney transplant recipients.
|
J Clin Microbiol
|
2013 Aug
|
Link
|
2014.4.30
|
Tey SK
|
Clinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV® assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complications.
|
PLoS One
|
2013 Oct
|
Link
|
2014.5.13
|
Manuel O
|
Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study.
|
Clin Infect Dis
|
2013 Mar
|
Link
|
2014.5.13
|
Lochmanova A
|
Quantiferon-CMV test in prediction of cytomegalovirus infection after kidney transplantation.
|
Transplant Proc
|
2010
|
Link
|
2014.5.13
|
Kumar D
|
Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients
|
Am J Transplant
|
2009
|
Link
|
2014.5.13
|
Walker S
|
Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON-CMV.
|
Transpl Infect Dis
|
2007
|
Link
|
2014.5.13
|